Skip to main content
Top

Open Access 05-06-2025 | Insulins | Article

BMP5 signalling in beta cells and the impact on insulin secretion in the context of type 2 diabetes

Authors: Esmée Dekker, Twan J. J. de Winter, Amadeo Muñoz Garcia, Natascha de Graaf, Maaike J. Roodzant, Eelco J. P. de Koning, Françoise Carlotti

Published in: Diabetologia

Login to get access

Abstract

Aims/hypothesis

Identifying signalling pathways that are important in pancreatic beta cell stress and failure can give insight into possible treatment options to prevent the loss of functional beta cell mass in diabetes. The bone morphogenetic protein (BMP)/SMAD family member BMP5 has been reported to be specifically expressed in human beta cells, but its function is unknown. Here we hypothesised that BMP5 plays a role in the maintenance of beta cell function.

Methods

We assessed the expression of BMP5 in publicly available single-cell RNA sequencing (scRNA-seq) datasets of primary human pancreatic islet cells from donors with or without type 2 diabetes, or islets exposed to stress conditions. Human islets and EndoC-βH1 cells were exposed to recombinant BMP5 and used for gene analysis, mitochondrial respiration and glucose-stimulated insulin secretion tests. In addition, we performed lentivirus‐mediated knockdown using short hairpin RNAs targeting BMP5 in human islets and EndoC-βH1 cells for gene expression and glucose-stimulated insulin secretion analyses.

Results

scRNA-seq data revealed that BMP5 is the most predominantly expressed BMP ligand in beta cells. BMP5 and its target genes are upregulated in beta cells from donors with type 2 diabetes. Enhanced BMP5 signalling triggered an upregulation of stress-related genes, and a reduction in glucose-stimulated mitochondrial oxygen consumption and insulin secretion. In contrast, downregulation of BMP5 in primary human islets enhanced beta cell function, which was associated with increased expression of key beta cell genes.

Conclusions/interpretation

Altogether, these findings point toward a role for BMP5 in the regulation of beta cell function.

Graphical Abstract

Appendix
This content is only visible if you are logged in and have the appropriate permissions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
BMP5 signalling in beta cells and the impact on insulin secretion in the context of type 2 diabetes
Authors
Esmée Dekker
Twan J. J. de Winter
Amadeo Muñoz Garcia
Natascha de Graaf
Maaike J. Roodzant
Eelco J. P. de Koning
Françoise Carlotti
Publication date
05-06-2025
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-025-06457-9

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more